Medadvisor Ltd (MDR) — Capital Reinvestment Ratio
Latest as of December 2023:
0.07x
Medadvisor Ltd (MDR) has a Capital Reinvestment Ratio of 0.07x as of December 2023, meaning it reinvests 0% of its operating cash flow (AU$11.04 Million) in capital expenditures (AU$821.44K). See cash generation quality of Medadvisor Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
AU$11.04 Million
AUD
Capital Expenditures
AU$821.44K
AUD
Data as of
Dec 2023
Most recent filing
Medadvisor Ltd Capital Reinvestment Ratio (2024–2024)
This chart tracks Medadvisor Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Medadvisor Ltd (2024–2024)
Year-by-year Capital Reinvestment Ratio for Medadvisor Ltd from 2024 to 2024. For live market cap and broader valuation context, see market value of Medadvisor Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | AU$5.19 Million | AU$1.83 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow